An Episodic Outbreak of Genetically Related Burkholdebja cepacia Among Non-Cystic Fibrosis Patients at a University Hospital

Infection Control

Volumn 22, Issue 7, 2001, Pages 419-422

  Siddiqui, Anwer H ^a,b   Mulligan, Maury E ^a,c   Mahenthiralingam, Eshwar ^d   Hebden, Joan ^b,c   Brewrink, Jeanine ^c   Qaiyumi, Sadaf ^a,b   Johnson, Judith A ^a   Lipuma, John J ^e,f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; CYSTIC FIBROSIS; EPIDEMIC; EPIDEMIOLOGICAL DATA; HOSPITAL INFECTION; HUMAN; OBSERVATION; PATHOGENESIS; PULSED FIELD GEL ELECTROPHORESIS;

ADULT; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HOSPITALS, TEACHING; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PATIENT ISOLATION; POLYMERASE CHAIN REACTION;

EID: 0034821566     PISSN: 01959417     EISSN: 23279451     Source Type: Journal    
DOI: 10.1086/501927     Document Type: Article

References (28)

1. Mangram A, Jarvis WR. Nosocomial Burkholderia cepacia outbreaks and pseudo-outbreaks. Infect Control Hosp Epidemiol 1996;17:718–720.
2. Govan, JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996;45:395–407.
3. LiPuma JJ. Burkholderia cepacia. Management issues and new insights. Clin Chest Med 1998;19:473–486.
4. Tablan OC. Nosocomially acquired Pseudomonas cepacia infection in patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993;14:124–126.
5. Pegues DA, Carson LA, Anderson RL, Norgard MJ, Argent TA, Jarvis WR, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis 1993;16:407–411.
6. Martone WJ, Tablan OC, Jarvis WR. The epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur J Epidemiol 1987;3:222–232.
7. Jarvis WR, Olson D, Tablan O, Martone WJ. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987;3:233–236.
8. Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang RZ, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999;179:1197–1205.
9. Sellick JA Jr. The use of statistical process control charts in hospital epidemiology. Infect Control Hosp Epidemiol 1993;14:649–656.
10. Henry DA, Campbell ME, LiPuma JJ, Speert DP Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 1997;35:614–619.
11. LiPuma JJ, Dulaney BJ, McMenamin JD, Whitby PW, Stull TL, Coenye X et al. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999;37:3167–3170.
12. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000;38:3165–3173.
13. Anderson DJ, Kuhns JS, Vasil ML, Gerding DN, Janoff EN. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol 1991;29:648–649.
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.
15. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808–816.
16. Sajjan US, Sun L, Goldstein R, Forstner JE Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995;177:1030–1038.
17. LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med 1998;4:337–341.
18. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53–80.
19. CDC Nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash-Arizona, 1998. MMWR 1998;47:926–928.
20. van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol 1998;19:112–113.
21. Okazaki M, Watanabe T, Morita K, Higurashi Y, Araki K, Shukuya N, et al. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks. J Clin Microbiol 1999;37:3809–3814.
22. Gravel-Tropper D, Sample ML, Oxley C, Toye B, Woods DE, Garber GE. Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol 1996;17:737–740.
23. Steere AC, Tenney JH, Mackel DC, Snyder MJ, Polakavetz S, Dunne ME, et al. Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis 1977;135:729–735.
24. LiPuma JJ, Mahenthiralingam E. Commercial use of Burkholderia cepacia. Emerg Infect Dis 1999;5:305–306.
25. LiPuma JJ, Spilker T, Gill L, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001;164:92–96.
26. Balandreau J, Viallard V, Cournoyer B, Coenye T, Laevens S, Vandamme P. Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Environ Microbiol 2001;67:982–985.
27. Gonzalez CF, Mark GL, Mahenthiralingam E, LiPuma JJ. Isolation of soilborne genomovar III Burkholderia cepacia and lytic phages with inter-genomovar host range. Pediatr Pulmonol 2000;20(suppl):288–289.
28. Miller SM, Parke JL, Bies S, LiPuma JJ. Detection, recovery and identification of Burkholderia cepacia from the natural environment. Pediatr Pulmonol 2000;20(suppl):288.